Skip to main content

Table 1 Baseline characteristics of the entire population

From: Sex differences in myocardial injury after non-cardiac surgery and postoperative mortality

 

Entire population

Male

(N = 18,546)

Female

(N = 14,765)

P value

SMD

Age

62.01 (13.4)

62.48 (14.0)

0.002

3.5

Diabetes

10,102 (54.5)

6819 (46.2)

 < 0.001

16.6

Hypertension

10,518 (56.7)

8187 (55.4)

0.02

2.5

Current smoking

3015 (16.3)

272 (1.8)

 < 0.001

51.9

Current alcohol

5398 (29.1)

1204 (8.2)

 < 0.001

55.9

Chronic kidney disease

1195 (6.4)

645 (4.4)

 < 0.001

9.2

History of ischemic heart disease

3356 (18.1)

1593 (10.8)

 < 0.001

20.9

History of heart failure

407 (2.2)

553 (3.7)

 < 0.001

9.1

History of stroke

1365 (7.4)

841 (5.7)

 < 0.001

6.7

History of arrhythmia

1382 (7.5)

820 (5.6)

 < 0.001

7.7

History of heart valve disease

188 (1.0)

240 (1.6)

 < 0.001

5.4

Active cancer

9274 (50.0)

5123 (34.7)

 < 0.001

31.4

Preoperative care

 Intensive care unit

768 (4.1)

475 (3.2)

 < 0.001

4.9

 ECMO

1 (0.0)

0 (0.0)

 > 0.99

1

 Continuous renal replacement therapy

50 (0.3)

30 (0.2)

0.26

1.4

 Ventilator

134 (0.7)

86 (0.6)

0.13

1.7

Operative variables

 ESC/ESA surgical high risk

4737 (25.5)

1978 (13.4)

 < 0.001

31

 Emergency operation

2668 (14.4)

1963 (13.3)

0.004

3.2

 General anesthesia

17,158 (92.5)

11,997 (81.3)

 < 0.001

33.8

 Operation duration, hours

3.38 (2.27)

2.80 (2.05)

 < 0.001

26.8

 Continuous infusion of inotropics

5447 (29.4)

4217 (28.6)

0.11

1.8

 RBC transfusion

1559 (8.4)

895 (6.1)

 < 0.001

9.1

  1. Data are presented as n (%) or mean (± standard deviation)
  2. SMD standardized mean difference, ECMO extracorporeal membranous oxygenation, RAAS renin–angiotensin–aldosterone system, ESC European society of cardiology, ESA European Society of Anaesthesiology, RBC red blood cell